SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-074169
Filing Date
2017-12-20
Accepted
2017-12-20 06:31:06
Documents
3
Period of Report
2017-12-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-28688_18k.htm 8-K 28285
2 EX-99.1 a17-28688_1ex99d1.htm EX-99.1 18586
3 GRAPHIC g286881mmi001.jpg GRAPHIC 2107
  Complete submission text file 0001104659-17-074169.txt   51391
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 171265655
SIC: 2834 Pharmaceutical Preparations